Syed F. Zafar, MD

Chief, Hematology and Oncology, Lee Health
Florida Cancer Specialists & Research Institute

n/a

Poster(s):

• 2009 - A phase 2 study of zanubrutinib in previously treated B-cell malignancies intolerant to ibrutinib and/or acalabrutinib: preliminary results for patients with CLL/SLL